Enovis ENOV
NYSE ENOV
$26.33 -0.17 (-0.66%)
At close: Aug 20, 2026 · 1:25 PM UTC

Enovis (ENOV) Other Accumulated Expenses (2010 - 2011)

Enovis (ENOV) posted quarterly Other Accumulated Expenses of $80.4 million for Q4 2011, up 75.15% year-over-year from $45.9 million in Q4 2010, and up 26.97% quarter-over-quarter from $63.4 million in Q3 2011.

Enovis (ENOV) Other Accumulated Expenses (2010 - 2011) Analysis & Trends

Enovis (ENOV) has reported Other Accumulated Expenses for 2 consecutive years, with $80.4 million the latest figure, recorded in Q4 2011.

  • In Q4 2011, Other Accumulated Expenses rose 75.15% year-over-year to $80.4 million; the TTM figure through Dec 2011 stood at $80.4 million (up 75.15% YoY), while the FY2011 annual figure was $80.4 million, up 75.15% from the prior year.
  • Other Accumulated Expenses advanced to $80.4 million in Q4 2011 per ENOV's latest filing, from $63.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $80.4 million in Q4 2011 and bottomed at $45.9 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn
10 Enovis 1.52 Bn 1.50 Bn 359.25 Mn

Historic Data

Download Data
DateValue
Dec 31, 2011 80.44 Mn
Sep 30, 2011 63.35 Mn
Jul 1, 2011 50.03 Mn
Dec 31, 2010 45.93 Mn